Research / HBIO / Fundamental state Inspectable configuration
State dimensions Filing 0001171843-26-001548 General Corporate
Debt relative to revenue 23th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.debt_to_revenue
41.44% · OPTIONAL · VALID
Capex intensity 38th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.45% · OPTIONAL · VALID
Operating cash generation 62th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
7.77% · OPTIONAL · VALID
Revenue growth 67th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.revenue
-8.06% · CORE · VALID
Inventory pressure 15th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
24.04% · OPTIONAL · VALID
Gross margin 38th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.gross_margin
57.67% · CORE · VALID
Operating margin 8th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.operating_margin
-56.13% · CORE · VALID
R&D intensity 8th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
10.20% · OPTIONAL · VALID
SBC intensity 8th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.14% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 16 states History building
Sep 30, 2022 0/8 normalized Level 3 Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/8 normalized Level 3 Jun 30, 2023 0/8 normalized Level 3 Sep 30, 2023 0/9 normalized Level 3 Dec 31, 2023 0/9 normalized Level 3 Mar 31, 2024 0/9 normalized Level 3 Jun 30, 2024 0/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 3 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 164.96%
Current 41.44%
Delta -123.52% Capex Intensity Increased
Previous 1.01%
Current 1.45%
Delta 0.45% Cash Generation Increased
Previous 5.26%
Current 7.77%
Delta 2.51% Growth Decreased
Previous -6.27%
Current -8.06%
Delta -1.79% Inventory Pressure Decreased
Previous 104.92%
Current 24.04%
Delta -80.88% Margin Decreased
Previous 58.38%
Current 57.67%
Delta -0.71% Profitability Decreased
Previous 0.96%
Current -56.13%
Delta -57.09% R And D Intensity Decreased
Previous 10.35%
Current 10.20%
Delta -0.16% Sbc Intensity Increased
Previous 1.57%
Current 2.14%
Delta 0.57% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.